The student nurse is taking a pharmacology course and studying the subject of access to new prescription drugs in Canada. Why might access to drugs be delayed and vary among the provinces and territories? Select all that apply.

Question

Quizplus · Accepted Answer

Access to drugs may be delayed and vary among provinces and territories in Canada due to different reasons. Once Health Canada approves a drug, it is up to each province and territory to decide whether or not to list the drug on their respective provincial formulary. Also, the cost of drugs can influence access, as some drugs may not be affordable or covered under certain drug benefit plans. Option A is incorrect as it suggests that there is no delay in getting drugs to the market, which may not be the case due to varying regulatory and approval processes. Option B is incorrect as the Common Drug Review (CDR) Directorate's role is to assess the clinical and cost-effectiveness of new drugs and provide recommendations to the provinces and territories, but the decision to list a drug ultimately rests with each jurisdiction.

The Student Nurse Is Taking a Pharmacology Course and Studying